Bank Of America Corp Alnylam Pharmaceuticals, Inc. Put Options Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $6.68 Million - $7.66 Million	-36,100 Reduced 97.57%	900 $170,000
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $6.43 Million - $8.29 Million	35,200 Added 1955.56%	37,000 $7.41 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $31 Million - $52 Million	-224,000 Reduced 99.2%	1,800 $360,000
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $27 Million - $37.9 Million	224,000 Added 12444.44%	225,800 $32.9 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $4.83 Million - $6.61 Million	-38,000 Reduced 95.48%	1,800 $294,000
Q2 2021 Sep 13, 2021	BUY	$128.63 - $176.89 $5.12 Million - $7.04 Million	39,800 New	39,800 $6.75 Million

614

108M

2.33M

2.17M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.